Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

House passes Trump-backed plan to avert government shutdown

by admin September 20, 2025
September 20, 2025
House passes Trump-backed plan to avert government shutdown

The House passed a short-term federal funding bill backed by President Donald Trump on Friday morning, paving the way for averting a government shutdown if the Senate follows suit.

The legislation is aimed at keeping the government funded at current levels through Nov. 21 with a measure known as a continuing resolution (CR), designed to give House and Senate appropriators more time to strike a deal on fiscal 2026 federal spending.

Fiscal 2025 is slated to end on Sept. 30, and Congress risks a partial shutdown if the CR does not make it to Trump’s desk for a signature by then.

In addition to keeping the government open until just before Thanksgiving, the legislation also includes an added $30 million to boost lawmaker security through a mutual aid fund for Capitol law enforcement and local police.

That decision was made as concerns over political violence have skyrocketed in recent months, including after the assassination of conservative activist Charlie Kirk in Utah last week.

The CR also honors a White House request for an additional $58 million in combined security funding for the judicial and executive branches, as well as $1 billion allocated for Washington, D.C.’s budget after Congress repealed that sum earlier this year.

A shutdown could be politically costly for both Republicans and Democrats.

Democratic leaders had threatened for days to oppose the bill, infuriated over being left out of CR negotiations and demanding increased funding for healthcare subsidies.

House Minority Leader Hakeem Jeffries, D-N.Y., was criticizing the CR as recently as Friday morning, less than an hour before the vote.

‘Today, there’s a choice before every single member of the House of Representatives: will we stand up for the healthcare of the American people, or will we bend the knee to Donald Trump and his continued efforts to gut healthcare for everyday Americans?’ Jeffries said.

‘We’re voting no on a partisan Republican spending bill, and we’ll continue to defend the healthcare of the American people.’

Speaker Mike Johnson, R-La., had precious little wiggle room going into the vote, affording to lose only two Republicans if all Democrats turned against it.

But in the Senate, where at least several Democratic votes will be needed to meet the 60-vote threshold to advance the legislation, Minority Leader Chuck Schumer, D-N.Y., is under significant pressure from his left flank to buck the GOP-led bill.

Schumer angered progressives in March when he cast a key vote to help avert a government shutdown with another Republican-led bill.

Republicans, meanwhile, have been readying to place the blame on a potential shutdown squarely on Democrats’ shoulders.

Trump posted on Truth Social on Thursday evening, ‘House Republicans are taking a very important Vote to pass a CLEAN TEMPORARY FUNDING BILL. The Leader of the Democrats, Cryin’ Chuck Schumer, wants to shut the Government down.’

‘Republicans want the Government to stay open. Every House Republican should UNIFY, and VOTE YES!’ Trump wrote.

Democrats released their own alternative CR plan this week, but Johnson told Fox News’ ‘Special Report’ that it was ‘filled with partisan wish lists and poison pills and demands.’

The Senate is expected to consider both versions and could take a vote as early as Friday.

This post appeared first on FOX NEWS

previous post
Kamala Harris says she ‘had no idea’ she ‘pulled the pin on a hand grenade’ with ‘The View’ answer about Biden
next post
Ben & Jerry’s co-founder resigns, claiming parent company Unilever ‘silenced’ its campaigning

Related Posts

Charlie Kirk honored by 90K in one of...

September 22, 2025

Trump admin guts Institute of Peace of ‘rogue...

March 20, 2025

Over 158 million Americans voted in 2024 as...

July 8, 2025

Jimmy Carter wins posthumous Grammy, sets record for...

February 3, 2025

Health experts prep Dem lawmakers on anti-vaccine arguments...

January 28, 2025

Zelenskyy to meet with Trump in Washington, DC...

August 16, 2025

Top federal agency with history of wasteful spending...

February 8, 2025

Political strategists lay out how Trump should kick...

March 4, 2025

Microsoft ends use of China-based computer engineers for...

July 19, 2025

Trump signs order lifting sanctions on Syria

July 1, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 5

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved